Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move
(TSXV: $WMD.V) (OTC: $SING) (CSE: $MYM.C) (CSE: $BILZ.C) (TSXV: $FAF.V)
(NASDAQ: $OPNT) (NYSE: $SNY)
Delta, Kelowna, BC –July 23,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/07231WMD-SING-MYM-BILZ-FAF-ONPT-SNY.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In today’s podcast we look at a few early
announcements.
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) announced that
it has launched CX Industries Inc., a wholly-owned subsidiary that will
specialize in extraction, toll processing and third-party product formulation
from WeedMD’s fully-licensed Aylmer, Ontario facility. CX Industries will have
the capacity to process more than 200,000 kgs of biomass at its peak production
in 2020.
“The launch of CX Industries represents
the next step in the evolution of WeedMD. The marriage of consistent low-cost
input material from our cultivation platform with our fully-licensed extraction
hub in Aylmer truly sets us apart. Our
management team is now working with strategic partners to provide a platform
for entrepreneurs and seasoned brands to enter the concentrates market,
building on our history of collaborating successfully with our peers in the
cannabis industry,” said Keith Merker, CEO of WeedMD. “We have a solid reputation
for executing on our production platforms – rooted in our integrity and
transparency, combined with our ability to scale. CX offers world-class extraction and
end-to-end production solutions as the market readies for the launch of
extracts later this year.”
The Company recently announced the
transition of its Aylmer, Ontario facility, now CX Industries, into a
large-scale cannabis extraction and processing hub. Together with its
greenhouse cultivation and outdoor grow that is in full operation at its Strathroy
facility, WeedMD is producing significant low-cost biomass input for
extraction.
SinglePoint Inc. (OTCQB:
SING) announced that
Direct Solar has surpassed everyone’s expectations signing contracts to deploy
$1,709,852 in solar installs over the past 30 days. Bringing the two month
totals to $3,419,312 in contracts, $1,687,886 in revenue and $757,700 in net.
Now that these are in contract they will move to the next phase in planning and
installation. Most of the revenue derived from these contracts will be
recognized throughout the third and fourth quarter. The previous 30 days should
generate approximately $884,117 in gross and $396,159 in net.
Currently Direct Solar is operational in
8 states and continues to expand its residential solar footprint. As the
company has solidified itself and proven the model, many financing companies
have approached the company to start a commercial financing division. The first
financing contract was signed last week and now the company will offer
renewable energy options to commercial operations and have the ability to
finance these larger scale projects. This additional market opens up a
tremendous amount of opportunity in a currently underserved market.
As solar continues to gain traction and
renewable energy becomes a top of mind conversation for many people, studies
continue to pile up. Most recently, CITE research in a nationally
representative poll found that 70% of people said they would support of version
a California’s solar mandate. This is not far off from the 2016 Pew Research
study that found 89% of Americans supported expanding rooftop solar.
In addition, according to Zion Market
Research, the global Solar Panel Market accounted for USD $30.8 Billion in 2016
and is expected to reach USD $57.3 billion by 2022 growing at a CAGR of 10.9%
between 2017 and 2022.
MYM Nutraceuticals Inc. (CSE:
MYM) (OTCBB:
MYMMF) announced that
its joint venture company (MYM owns 50%), BioHemp Naturals Growing &
Farming Ltd. ("BioHemp"), has signed a non-binding Letter of Intent
("LOI") for the sale of $25 million of CBD-rich hemp biomass.
"I am truly excited to share that
our sales team has secured a LOI for $25 million, representing nearly half of
our remaining forecasted CBD-rich hemp biomass," said Howard Steinberg,
CEO of MYM. "The recipient of the biomass represents a consortium of Canada's
largest cannabis LP's and is a great vote of confidence to the quality of
BioHemp's Canadian grown CBD-rich hemp."
Fire & Flower Holdings Corp. and
its wholly-owned subsidiary Fire &
Flower Inc. (TSXV:
FAF), today
announced that it has received its licence to operate
a cannabis retail store in Whitehorse, Yukon from the Yukon Liquor Corporation,
Cannabis Licensing.
Upon opening, this will be the 24th
Fire & Flower branded, licensed cannabis store and will be located at #110,
80 Chilkoot Way, Whitehorse, Yukon.
In addition to continuing to deliver on
Fire & Flower's rapid near-term rollout schedule, the receipt of a licence
in the Yukon territory demonstrates Fire & Flower's ability to successfully
open cannabis retail stores in provinces across Canada where private cannabis
retail is permitted.
"The receipt of a cannabis retail
store licence in the Yukon demonstrates Fire & Flower's ability to
successfully open retail stores rapidly across multiple jurisdictions with
varying regulatory requirements," shared Trevor Fencott, Fire &
Flower's Chief Executive Officer. "The opening of a Fire & Flower
store in this northern Canadian market will enable us to further understand
cannabis purchasing preferences through our proprietary Hifyre digital platform,
that in turn will allow us to better tailor our experience to local markets. We
look forward to becoming members of the Whitehorse community and welcoming
local customers into our store."
Fire & Flower will announce the
opening date and time of the Whitehorse store at its earliest opportunity on
its website at www.fireandflower.com/locations/.
Ignite International, Ltd., a
wholly owned subsidiary of Ignite
International Brands, Ltd. (CSE:BILZ), today
announced that it has signed a joint venture
agreement with Grupo Ensejal, S.A. de C.V. The joint venture, which will
operate as a newly formed legal entity, will encompass convenience, specialty
retail, pharmacy and e-commerce retail channels.
"Ignite is quickly becoming a global
powerhouse brand and expanding to our neighbors to the south was a natural next
step. The creation of the Mexican joint venture gives Ignite first mover
positioning in Mexico to build relationships and trust with retailers and
buyers," said Jim McCormick, President of Ignite International Brands,
Ltd., "Grupo Ensejal is the perfect partner for us as they get the power
of Dan Bilzerian's global reach and understand the power of smart marketing
when creating brands."
The joint venture will draw on Ignite's
marketing expertise and the brand recognition of the Ignite trademark, the
iconic goat's skull logo and founder Dan Bilzerian who has amassed a global
social media fan base of over 44 million followers across the leading social
media platforms.
Added Roberto Celaya Burruel, Partner of
Grupo Ensejal, "We are excited to be a part of the rapid expansion of the
Ignite brand and bringing it to Mexico. We have been watching what Dan
Bilzerian has been doing with Ignite over the past year in the United States
and we are confident we can continue the buzz for our neighbors to the
north."
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a
specialty pharmaceutical company developing medicines for addictions and drug
overdose, today
announced that it has signed an agreement with Sanofi (NYSE:SNY) to
manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the
treatment of Acute Cannabinoid Overdose (ACO). Opiant intends to reformulate
drinabant, a high affinity, selective cannabinoid receptor antagonist, for
parenteral administration in an emergency department setting. Opiant licensed
exclusive global rights from Sanofi for the development and commercialization
of drinabant for the emergency treatment of ACO. The manufacturing will be
performed in Sanofi Újpest site (Hungary) acting as a Contract Development and
Manufacturing Organization (CDMO).
“This agreement marks an important
milestone in our partnership with Sanofi and the OPNT004 development program
and supply chain,” said Roger Crystal, M.D., Chief Executive Officer of Opiant.
“This further enhances our position as a leader in developing medicines for the
treatment of addiction and drug overdose.”
ACO is most often linked to the ingestion
of both “edibles”, products containing large quantities of D9-tetrahydrocannabinol
(THC) that are often sold as brownies, cookies, and candies, and synthetic
cannabinoids (sold with names such as “K2” and “Spice”) that are more potent,
easily obtained, and less expensive than cannabis containing products. It is
estimated that ACO resulted in more than one million emergency department
visits in the United States in 2016, and is expected to rise with increasing
legalization of cannabis in North America. Features of ACO can include
psychosis, hallucinations, nausea and
vomiting, as well as feelings of paranoia, agitation, panic and anxiety. These
symptoms often require emergency medical attention and can take from hours to days
to fully resolve. There are currently no approved treatments for ACO.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
